|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ИНХС РАН |
||
What is important for doctor’s drug decision-making for the patient with acute schizophreniaстатья Тезисы
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или ScopusДата последнего поиска статьи во внешних источниках: 23 сентября 2021 г.
- Авторы: Morozova M., Rupchev G.
- Журнал: European Psychiatry
- Том: 64
- Год издания: 2021
- Издательство: Cambridge University Press
- Местоположение издательства: United Kingdom
- Первая страница: 649
- Последняя страница: 649
- DOI: 10.1192/j.eurpsy.2021.7
- Аннотация: In spite of the long history of antipsychotic treatment there are still no clear features of the mental illness, which can be robust clinical signs, which determine the choice of the antipsychotic.The data from the case history charts of 275 patients with episodic schizophrenia with rather benign course of the disease were analyzed in order to determine the important hallmarks of patients psychotic state, life span and history of illness, which impact the doctor’s decision, what type of antipsychotic should be chosen. The analyzed group included as follows: male 62%, mean age 33 (SD 11 years), education 10 years 23%, 13 years 27%, 16 years 29%, disability - 51%, number of hospitalizations due to psychotic episodes in the past– 7 (SD 6). The symptoms of the current episode varied from patient to patient: there were delusions and hallucinations, symptoms of disorganization, negative symptoms of different severity. It appeared that the most important for the decision was the specific features of patient’s development and early period of the disease, but not the specific signs of current psychotic state. Results. Atypical antipsychotic were more often prescribed to the patients with developmental problems: traumatic obstetric complications (p=0,009), poor somatic health in the childhood (p= 0,02), cognitive dysfunction during school years (p=0,04), and quality of first remission – presence of residual symptoms in the first remission (p=0.005). Good compliance in the past was one more important factor for choosing of atypical antipsychotic for the patient (p=0.05). Conclusion. Doctor’s decision upon the type of antipsychotics in this category of patients is most probably based on other than current state features.
- Добавил в систему: Рупчев Георгий Евгеньевич
Прикрепленные файлы
| № | Имя | Описание | Имя файла | Размер | Добавлен |
|---|---|---|---|---|---|
| 1. | презентация | What_is_important_1.pptx | 361,0 КБ | 20 апреля 2022 [George72] | |
| 2. | Полный текст | drug_decision-making_scan.docx | 258,9 КБ | 22 апреля 2021 [George72] |